Thermo Fisher Scientific (TMO)
(Delayed Data from NYSE)
$596.92 USD
+3.13 (0.53%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $596.52 -0.40 (-0.07%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth D Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$596.92 USD
+3.13 (0.53%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $596.52 -0.40 (-0.07%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth D Momentum D VGM
Zacks News
The Zacks Analyst Blog Highlights: Turning Point Brands, Medifast, Emergent BioSolutions, Thermo Fisher Scientific and Sempra Energy
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Turning Point Brands, Medifast, Emergent BioSolutions, Thermo Fisher Scientific and Sempra Energy
The Zacks Analyst Blog Highlights: Microsoft, Tesla, Thermo Fisher Scientific, ABB and Suncor Energy
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Microsoft, Tesla, Thermo Fisher Scientific, ABB and Suncor Energy
Jobless Claims Rise First Time Since March: 5 Defensive Picks
by Sreoshi Bera
The spike in unemployment claims and looming coronavirus fears have made markets volatile, making defensive picks lucrative investment options.
Top Stock Reports for Microsoft, Tesla & Thermo Fisher
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Microsoft (MSFT), Tesla (TSLA) and Thermo Fisher Scientific (TMO).
Company News for Jul 23, 2020
by Zacks Equity Research
Companies In The News Are: HCA, TMO, ABB, APH.
Should You Buy the Rally in Non-US Stocks?
by John Blank
Or does global growth need to show up first???
Has Thermo Fisher Scientific (TMO) Outpaced Other Medical Stocks This Year?
by Zacks Equity Research
Is (TMO) Outperforming Other Medical Stocks This Year?
Thermo Fisher (TMO) Q2 Earnings Beat on COVID-19-Led Sales
by Zacks Equity Research
We are encouraged about Thermo Fisher's (TMO) exceptionally strong year-over-year revenue growth at Life Sciences Solutions segment.
Here's Why You Should Add QIAGEN (QGEN) to Your Portfolio
by Zacks Equity Research
Investors continue to be optimistic about QIAGEN (QGEN) on robust segmental and geographical growth.
Can Diagnostics Aid Hologic (HOLX) Q3 Earnings Amid Coronavirus?
by Zacks Equity Research
Strength in segmental business is likely to have aided Hologic's (HOLX) performance in third-quarter fiscal 2020 amid the coronavirus-led economic doldrums.
Thermo Fisher Scientific (TMO) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
Thermo Fisher (TMO) delivered earnings and revenue surprises of 45.69% and 0.10%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Growing Testing Capacity to Aid LabCorp's (LH) Q2 Earnings?
by Zacks Equity Research
LabCorp's (LH) developments to support COVID-19 testing are believed to have contributed to the company's second-quarter earnings.
The Zacks Analyst Blog Highlights: Thermo Fisher Scientific, Lithia Motors, Quest Diagnostics, Pool and Boston Beer
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Thermo Fisher Scientific, Lithia Motors, Quest Diagnostics, Pool and Boston Beer
Why Earnings Season Could Be Great for Thermo Fisher (TMO)
by Zacks Equity Research
Thermo Fisher (TMO) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
4 Top Stocks to Buy Ahead of Earnings Release
by Zacks Equity Research
Healthcare, consumer staples and retail sectors could be ideal investments right now, keeping in mind the growing demand for their products.
Amkor (AMKR) Gears Up for Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Healthy growth in the consumer and communication end market is likely to reflect on Amkor Technology's (AMKR) Q2 results. Yet, uncertainty owing to the coronavirus outbreak may have been a concern.
EDAP TMS (EDAP) Catches Eye: Stock Jumps 7.4%
by Zacks Equity Research
EDAP TMS (EDAP) saw a big move last session, as its shares jumped more than 7% on the day, amid huge volumes.
5 Top-Ranked Stocks Poised to Beat on Q2 Earnings This Week
by Nalak Das
We have narrowed down our search to five Zacks Rank #1 stocks slated to release earrings results this week with a positive Earnings ESP.
Testing Volume to Aid Quest Diagnostics' (DGX) Q2 Earnings?
by Zacks Equity Research
Looking at this demand for testing, Quest Diagnostics (DGX) has significantly picked up capacity to perform molecular diagnostic tests a day.
What's in Store for West Pharmaceutical's (WST) Q2 Earnings?
by Zacks Equity Research
West Pharmaceutical Services (WST) is likely to have gained from continued strength in high-value product sales in Q2.
What's in the Cards for Intuitive Surgical (ISRG) Q2 Earnings?
by Zacks Equity Research
Intuitive Surgical's (ISRG) second-quarter earnings are likely to reflect weaker-than-expected performance at Instruments & Accessories segment and decline in da Vince procedure volume.
Top Ranked Momentum Stocks to Buy for July 17th
by Zacks Equity Research
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, July 17th
3 Inexpensive MedTech Gainers of 2H20 Beyond TMO and RMD
by Zacks Equity Research
Here we look at three cheap MedTech stocks that investors can take a look at apart from giants like Thermo Fisher and ResMed that are expensive.
Luminex (LMNX) Catches Eye: Stock Jumps 7.1%
by Zacks Equity Research
Luminex (LMNX) saw a big move last session, as its shares jumped more than 7% on the day, amid huge volumes.
What's in Store for Edwards Lifesciences (EW) in Q2 Earnings?
by Zacks Equity Research
Robust customer adoption of the TruWave disposable pressure monitoring devices and INSPIRIS RESILIA aortic valve are likely to have driven Edwards Lifesciences' (EW) Q2 revenues.